Indication
Colorectal Cancer Stage III
2 clinical trials
1 product
3 drugs
Product
RO7198457Clinical trial
A Multi-site, Open-label, Phase II, Randomized, Controlled Trial to Compare the Efficacy of RO7198457 Versus Watchful Waiting in Resected, Stage II (High Risk) and Stage III Colorectal Cancer Patients Who Are ctDNA Positive Following ResectionStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal CancerStatus: Active (not recruiting), Estimated PCD: 2026-10-18
Drug
mFOLFOX6Drug
UTD1Drug
PD-1 antibody